Expertise in
43
conditions

Michel G. Polak

Paris, FR 
Expertise in
43
conditions
Paris, FR 

Overview

Michel Polak practices practicing medicine in Paris, France.

Mr. Polak is highly rated in 43 conditions, according to our data. His clinical expertise encompasses Thyroid Dysgenesis, Congenital Hypothyroidism, Hypothyroidism, Hypopituitarism, and Hormone Replacement Therapy (HRT).

He is actively involved in clinical research, co-authoring 248 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Paris, France
Other Locations
France
78 Rue Du Général Leclerc, Plasnes, 94270, France
157 Rue De La Porte De Trivaux, Clamart, 92140, France
Bondy, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Efficacy and Safety Evaluation of Recombinant Human Growth Hormone (r-hGH), Saizen®, on a Population of Children With Hypochondroplasia, Treated Over a Period of 3 Years or 5 Years if Applicable, in Comparison With a Historic Cohort of Non-treated Children With Hypochondroplasia
Efficacy and Safety Evaluation of Recombinant Human Growth Hormone (r-hGH), Saizen®, on a Population of Children With Hypochondroplasia, Treated Over a Period of 3 Years or 5 Years if Applicable, in Comparison With a Historic Cohort of Non-treated Children With Hypochondroplasia
Enrollment Status: Completed
Publish Date: February 15, 2019
Intervention Type: Drug
Study Phase: Phase 2

248 Total Publications

Surgical Morbidity and Short-Term Oncologic Status after Prophylactic-Intent Thyroidectomy in a Cohort of Children with MEN2 from the Multicenter GTE ENDOCAN-RENATEN Study.
Surgical Morbidity and Short-Term Oncologic Status after Prophylactic-Intent Thyroidectomy in a Cohort of Children with MEN2 from the Multicenter GTE ENDOCAN-RENATEN Study.
Journal: Thyroid : official journal of the American Thyroid Association
Published: August 07, 2026

Frequently Asked Questions about Michel G. Polak

Is Michel G. Polak a top-rated expert for Thyroid Dysgenesis?

MediFind is an objective health platform that identifies experts based on real-world data. Michel G. Polak is classified as an Elite expert for Thyroid Dysgenesis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Michel G. Polak participate in research or clinical trials?

Yes. Michel G. Polak has published 248 articles and abstracts on conditions like Thyroid Dysgenesis. You can view a list of Michel G. Polak's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Polak's expertise for a condition
ConditionClose
View All 8 Elite Conditions
View All 12 Distinguished Conditions
View All 23 Advanced Conditions
View All 77 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile